InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $4.000 0.1 (2.44%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,406 Release of restricted securities from escrow 21 Dec 2020 1:36PM $2.270 $4.000 risen by 76.21%
$2,406 4DMedical completes first commercial scan in Australia 18 Dec 2020 9:09AM $2.110 $4.000 risen by 89.57%
$2,406 S&P DJI Announces December 2020 Quarterly Rebalance 11 Dec 2020 5:10PM $2.150 $4.000 risen by 86.05%
$2,406 Ceasing to be a substantial holder 11 Dec 2020 4:35PM $2.150 $4.000 risen by 86.05%
$2,406 Appendix 2A 10 Dec 2020 2:40PM $2.230 $4.000 risen by 79.37%
$2,406 Release of restricted securities from escrow 10 Dec 2020 2:35PM $2.230 $4.000 risen by 79.37%
$2,406 Research program with University of Miami Health System 2 Dec 2020 8:53AM $2.350 $4.000 risen by 70.21%
$2,406 Results of Meeting 20 Nov 2020 2:07PM $2.200 $4.000 risen by 81.82%
$2,406 2020 Annual General Meeting presentation 20 Nov 2020 9:48AM $2.150 $4.000 risen by 86.05%
$2,406 Chairman's Address to Shareholders 20 Nov 2020 9:44AM $2.150 $4.000 risen by 86.05%
$2,406 Appendix 2A 18 Nov 2020 2:05PM $2.170 $4.000 risen by 84.33%
$2,406 Release of restricted securities from escrow 18 Nov 2020 1:52PM $2.150 $4.000 risen by 86.05%
$2,406 4DMedical to present at virtual conference 4 Nov 2020 11:25AM $2.270 $4.000 risen by 76.21%
$2,406 Quarterly Activity Report and Appendix 4C for Q1 FY2021 29 Oct 2020 8:50AM $2.360 $4.000 risen by 69.49%
$2,406 Appendix 2A 22 Oct 2020 2:07PM $2.140 $4.000 risen by 86.92%
$2,406 2020 Notice of Annual General Meeting 19 Oct 2020 2:32PM $2.510 $4.000 risen by 59.36%
$2,406 Release of restricted securities from escrow 16 Oct 2020 1:03PM $2.580 $4.000 risen by 55.04%
$2,406 4DMedical Goldman Sachs Healthcare Forum Presentation 8 Oct 2020 8:42AM $1.665 $4.000 risen by 140.24%
$2,406 2020 Annual General Meeting 1 Oct 2020 4:18PM $1.690 $4.000 risen by 136.69%
$2,406 4DMedical receives TGA approval for XV LVAS 30 Sep 2020 10:13AM $1.525 $4.000 risen by 162.30%
$2,406 Trading Halt 29 Sep 2020 12:45PM $1.525 $4.000 risen by 162.30%
$2,406 Appendix 4G and Corporate Governance Statement 24 Sep 2020 8:17AM $1.590 $4.000 risen by 151.57%
$2,406 2020 Annual Report 24 Sep 2020 8:17AM $1.590 $4.000 risen by 151.57%
$2,406 FY20 Full Year Results 28 Aug 2020 2:54PM $1.435 $4.000 risen by 178.75%
$2,406 Appendix 4E - Preliminary Final Report 28 Aug 2020 2:49PM $1.435 $4.000 risen by 178.75%

551 - 575 of 604 results

Page 23 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.